Ameritas Investment Partners’s Cabaletta Bio CABA Stock Holding History

Ameritas Investment Partners’s Portfolio CABA Stock Details CABA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$31.8K	Buy	+10,217	New	+$33.6K	﹤0.01%	2517
2025 Q2	–	Sell	-3,452	Closed	-$4.78K	–	3219
2025 Q1	$4.78K	Hold	3,452	–	–	﹤0.01%	2979
2024 Q4	$7.84K	Hold	3,452	–	–	﹤0.01%	2961
2024 Q3	$16.3K	Hold	3,452	–	–	﹤0.01%	2739
2024 Q2	$25.8K	Hold	3,452	–	–	﹤0.01%	2505
2024 Q1	$58.9K	Hold	3,452	–	–	﹤0.01%	2053
2023 Q4	$78.4K	Hold	3,452	–	–	﹤0.01%	1900
2023 Q3	$52.5K	Buy	3,452 +1,340	+63%	+$18.3K	﹤0.01%	2077
2023 Q2	$27.3K	Buy	+2,112	New	+$22.9K	﹤0.01%	2394
2021 Q2	–	Sell	-1,125	Closed	-$12K	–	3077
2021 Q1	$12K	Hold	1,125	–	–	﹤0.01%	2768
2020 Q4	$14K	Hold	1,125	–	–	﹤0.01%	2640
2020 Q3	$12K	Buy	1,125 +565	+101%	+$6.49K	﹤0.01%	2623
2020 Q2	$6K	Hold	560	–	–	﹤0.01%	2911
2020 Q1	$4K	Hold	560	–	–	﹤0.01%	2861
2019 Q4	$8K	Buy	+560	New	+$6.64K	﹤0.01%	2798

Other funds holding CABA

Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

BCLSI

Bain Capital Life Sciences Investors Boston, Massachusetts $1.68B AUM 126.09% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

CAM

Cormorant Asset Management Boston, Massachusetts $1.95B AUM 773.9% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return

Ameritas Investment Partners's CABA Position: Q2 2026 in Review

Ameritas Investment Partners opened a new position in Cabaletta Bio (CABA) in Q2 2026: 10,217 shares worth $31.8K. The stake represents ﹤0.01% of the portfolio and ranks #2517 among its holdings. This is a return to the name: Ameritas Investment Partners previously reported a position in CABA as recently as Q1 2025.

Ameritas Investment Partners first reported a position in CABA in Q4 2019 and has held it in 15 quarters since. The position peaked at $78.4K in Q4 2023. 139 funds tracked by Wall St. Rank hold CABA as of Q2 2026.

Ameritas Investment Partners held 10,217 shares of Cabaletta Bio worth $31.8K as of Q2 2026.
Cabaletta Bio was a new Ameritas Investment Partners position in Q2 2026.
Cabaletta Bio made up ﹤0.01% of Ameritas Investment Partners's portfolio in Q2 2026, its #2517 holding.
Ameritas Investment Partners first reported a position in Cabaletta Bio in Q4 2019 and has held it in 15 quarters since.
Ameritas Investment Partners's Cabaletta Bio position peaked at $78.4K in Q4 2023.
139 funds tracked by Wall St. Rank held Cabaletta Bio as of Q2 2026.

Based on Ameritas Investment Partners's 13F filing for Q2 2026, filed 13 Aug 2026.